Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in

Insulet Corp
SWB:GOV

Watchlist Manager
Insulet Corp Logo
Insulet Corp
SWB:GOV
Watchlist
Price: 112.85 EUR -21.96% Market Closed
Market Cap: €7.9B
Write Note Create Alert

Intrinsic Value

Is GOV undervalued or overvalued?

See the intrinsic value estimate for Insulet Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

GOV Intrinsic Value
LOCKED
Unlock
Today vs. history

GOV looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with GOV’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor GOV
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price €112.85
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to GOV

Fundamental Analysis

What Insulet Does

Health Care

Insulet makes wearable insulin delivery systems for people with diabetes. Its main product is the Omnipod line, a small tubeless pump that sticks to the body and automatically delivers insulin without the need for repeated injections. The company also provides the disposable pods, the controller or app that manages dosing, and training and support for patients and healthcare providers.

Headquarters
United States of America US
Employees
5 400
IPO date
May 15, 2007
Read the full company overview
View Company Overview

Insulet has a narrow economic moat

No Moat Narrow Wide

Patents make Omnipod’s insulin-delivery technology harder to copy, while changing pumps requires patients to learn a different system and review treatment settings with their care team. Together, these barriers help Insulet retain customers without making competing pumps impossible to develop or adopt.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Insulet Corp

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

PODD Insider Trading
Buy and sell transactions by insiders

Continue GOV Research

Summary
GOV intrinsic value, competitors valuation, and company profile.
DCF Valuation
GOV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GOV stock valuation using valuation multiples.
Wall St Estimates
GOV price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GOV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Insulet Corp listings:
NASDAQ • USD
PODD
 F • EUR
GOV
 XMUN • EUR
GOV
Discover More
What is the Intrinsic Value of one GOV stock?

The intrinsic value for Insulet Corp (GOV) under the Base Case is hidden EUR.

Is GOV stock undervalued or overvalued?

Compared with the current market price of 112.85 EUR, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 362,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.